Literature DB >> 7862819

Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats.

G C Harris1, G Aston-Jones.   

Abstract

Rats were treated chronically with either cocaine (20 mg/kg/day, 14 days), morphine (incrementing doses of 10 mg/kg/day to 80 mg/kg, 11 days) or saline. During morphine or cocaine abstinence (48 h), dependent rats showed increased anxiety-like behavior in a conditioned defensive burying paradigm as evidenced by significantly shorter latencies to begin burying as well as a 4-fold increase in burying duration relative to saline-treated animals. This withdrawal-induced increase in burying behavior was blocked by pretreatment with either the beta-adrenergic antagonist propranolol (5 mg/kg) or the lipophobic selective beta 1-antagonist, atenolol (5 mg/kg). These results are consistent with the possibility that activation of peripheral beta 1 receptors may substantially contribute to withdrawal-induced anxiety and that beta-adrenergic antagonists could be useful in treating in cocaine and morphine dependent addicts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7862819     DOI: 10.1007/bf02244345

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Direct evidence for an interaction of beta-adrenergic blockers with the 5-HT receptor.

Authors: 
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

2.  Treatment of cocaine-induced panic disorder.

Authors:  A K Louie; R A Lannon; T A Ketter
Journal:  Am J Psychiatry       Date:  1989-01       Impact factor: 18.112

3.  Effects of some beta-adrenoceptor blockers on avoidance learning in rats.

Authors:  D Staneva-Stoytcheva; A Astrug; D Ivanov
Journal:  Methods Find Exp Clin Pharmacol       Date:  1989-09

4.  Propranolol in withdrawal from opiates.

Authors:  L E Hollister; J J Prusmack
Journal:  Arch Gen Psychiatry       Date:  1974-11

5.  Animal models for the study of anti-anxiety agents: a review.

Authors:  D Treit
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

6.  The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse.

Authors:  B Costall; M E Kelly; E S Onaivi; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

7.  Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

Authors:  F H Gawin; H D Kleber
Journal:  Arch Gen Psychiatry       Date:  1986-02

8.  Withdrawal from morphine generalizes to a pentylenetetrazol stimulus.

Authors:  M W Emmett-Oglesby; C M Harris; J D Lane; H Lal
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

9.  Mianserin in the treatment of ethanol withdrawal in the rat: prevention of behaviors indicative of anxiety.

Authors:  P L Prather; S M Rezazadeh; H Lal
Journal:  Psychopharmacol Bull       Date:  1991

10.  Naloxone, preshock, and defensive burying.

Authors:  D A Whiteside; L D Devenport
Journal:  Behav Neurosci       Date:  1985-06       Impact factor: 1.912

View more
  49 in total

1.  Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors.

Authors:  John R Mantsch; Andy Weyer; Oliver Vranjkovic; Chad E Beyer; David A Baker; Holly Caretta
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

2.  β-adrenergic receptor mediation of stress-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: roles for β1 and β2 adrenergic receptors.

Authors:  Oliver Vranjkovic; Shona Hang; David A Baker; John R Mantsch
Journal:  J Pharmacol Exp Ther       Date:  2012-05-16       Impact factor: 4.030

3.  Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal.

Authors:  Glenda C Harris; Gary Aston-Jones
Journal:  Behav Brain Res       Date:  2006-11-22       Impact factor: 3.332

4.  Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function.

Authors:  G C Harris; M Hummel; M Wimmer; S D Mague; G Aston-Jones
Journal:  Neuroscience       Date:  2007-06-07       Impact factor: 3.590

Review 5.  Safety considerations in treating concomitant diseases in patients with asthma.

Authors:  L W Hunt
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

6.  Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.

Authors:  Zhongqi Zhang; Andrew C Morse; George F Koob; Gery Schulteis
Journal:  Alcohol Clin Exp Res       Date:  2007-09-14       Impact factor: 3.455

7.  Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus.

Authors:  M I Read; J C Harrison; D S Kerr; I A Sammut
Journal:  Br J Pharmacol       Date:  2015-08-24       Impact factor: 8.739

Review 8.  Norepinephrine and stimulant addiction.

Authors:  Mehmet Sofuoglu; R Andrew Sewell
Journal:  Addict Biol       Date:  2008-09-22       Impact factor: 4.280

9.  Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism.

Authors:  Shawn M Vuong; Harvey A Oliver; Jamie L Scholl; Kathryn M Oliver; Gina L Forster
Journal:  Behav Brain Res       Date:  2009-12-01       Impact factor: 3.332

10.  Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area.

Authors:  Eric C Dumont; John T Williams
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.